Milk consumption and the risk of type 2 diabetes: A systematic review of Mendelian randomization studies

被引:1
|
作者
Jensen, Christopher Fisker [1 ,4 ]
Timofeeva, Maria [2 ]
Berg-Beckhoff, Gabriele [3 ]
机构
[1] Univ Southern Denmark, Dept Publ Hlth, Esbjerg, Denmark
[2] Univ Southern Denmark, Danish Inst Adv Study, Dept Publ Hlth, Epidemiol Biostat & Biodemog, Odense, Denmark
[3] Univ Southern Denmark, Hlth Promot, Esbjerg, Denmark
[4] Degnevej 14, DK-6705 Esbjerg O, Denmark
关键词
Milk; Dairy; Type; 2; diabetes; Nutrition; Mendelian randomization; Systematic review;
D O I
10.1016/j.numecd.2023.04.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Previously, no relationship between milk consumption and the risk of type 2 diabetes has been found in prospective cohorts. However, Mendelian randomization allows re-searchers to almost bypass much residual confounding, providing a more precise effect estimate.This systematic review aims to investigate the risk of type 2 diabetes and levels of HbA1c by assessing all Mendelian Randomization studies investigating this subject matter. Data synthesis: PubMed and EMBASE were searched from October 2021 through February 2023. Inclusion and exclusion criteria were formulated to filter out irrelevant studies. Studies were qualitatively assessed with STROBE-MR together with a list of five MR criteria. Six studies were identified, containing several thousand participants. All studies used the SNP rs4988235 as the main exposure and type 2 diabetes and/or HbA1c as the main outcome. Five studies were graded as "good" with STROBE-MR, with one graded as "fair". For the six MR criteria, five studies were graded "good" in four criteria, while two studies were graded "good" in two criteria. Overall, genetically predicted milk consumption did not seem to be associated with an increased risk of type 2 diabetes.Conclusions: This systematic review found that genetically predicted milk consumption did not seem to increase the risk of type 2 diabetes. Future Mendelian randomization studies concerning this topic should consider conducting two-sample Mendelian Randomization studies, in order to derive a more valid effect estimate.& COPY; 2023 The Author(s). Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:1316 / 1322
页数:7
相关论文
共 50 条
  • [1] Systematic review of Mendelian randomization studies on risk of cancer
    Georgios Markozannes
    Afroditi Kanellopoulou
    Olympia Dimopoulou
    Dimitrios Kosmidis
    Xiaomeng Zhang
    Lijuan Wang
    Evropi Theodoratou
    Dipender Gill
    Stephen Burgess
    Konstantinos K. Tsilidis
    [J]. BMC Medicine, 20
  • [2] Systematic review of Mendelian randomization studies on risk of cancer
    Markozannes, Georgios
    Kanellopoulou, Afroditi
    Dimopoulou, Olympia
    Kosmidis, Dimitrios
    Zhang, Xiaomeng
    Wang, Lijuan
    Theodoratou, Evropi
    Gill, Dipender
    Burgess, Stephen
    Tsilidis, Konstantinos K.
    [J]. BMC MEDICINE, 2022, 20 (01)
  • [3] Mendelian randomization studies of biomarkers and type 2 diabetes
    Abbasi, Ali
    [J]. ENDOCRINE CONNECTIONS, 2015, 4 (04) : 249 - 260
  • [4] Type 2 Diabetes and Cancer: An Umbrella Review of Observational and Mendelian Randomization Studies
    Pearson-Stuttard, Jonathan
    Papadimitriou, Nikos
    Markozannes, Georgios
    Cividini, Sofia
    Kakourou, Artemisia
    Gill, Dipender
    Rizos, Evangelos C.
    Monori, Grace
    Ward, Heather A.
    Kyrgiou, Maria
    Gunter, Marc J.
    Tsilidis, Konstantinos K.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (06) : 1218 - 1228
  • [5] Mendelian Randomization Studies of the Role of Biomarkers in Type 2 Diabetes
    Perry, John
    Zeggini, Ele
    Scott, Laura
    Saxena, Richa
    Voight, Ben
    Ferrucci, Luigi
    Maggio, Marcello
    Paolisso, Giuseppe
    Sparso, Thomas
    Langenberg, Claudia
    Grallert, Harald
    Palmer, Colin
    Morris, Andrew
    Steinthorsdottir, Valgerdur
    Jackson, Anne
    Thorsteinsdottir, Unnur
    Stefansson, Kari
    Boehnke, Michael
    Hansen, Torben
    Pedersen, Oluf
    Illig, Thomas
    Wareham, Nick
    Barroso, Ines
    Hattersley, Andrew
    McCarthy, Mark
    Frayling, Timothy
    [J]. DIABETES, 2009, 58 : A311 - A311
  • [6] Depression and type 2 diabetes risk: a Mendelian randomization study
    Liu, Kaiyuan
    Zhou, Diyi
    Chen, Lijun
    Hao, Sida
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [7] ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study
    Pigeyre, Marie
    Sjaarda, Jennifer
    Chong, Michael
    Hess, Sibylle
    Bosch, Jackie
    Yusuf, Salim
    Gerstein, Hertzel
    Pare, Guillaume
    [J]. DIABETES CARE, 2020, 43 (04) : 835 - 842
  • [8] Mendelian Randomization and Type 2 Diabetes
    Daniel I. Swerdlow
    [J]. Cardiovascular Drugs and Therapy, 2016, 30 : 51 - 57
  • [9] Mendelian Randomization and Type 2 Diabetes
    Swerdlow, Daniel I.
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2016, 30 (01) : 51 - 57
  • [10] Coffee consumption and risk of type 2 diabetes - A systematic review
    van Dam, RM
    Hu, FB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (01): : 97 - 104